Poly(D,L-lactide-co-glycolide) (85:15)

Product Name	Poly(D,L-lactide-co-glycolide) (85:15)
Synonym(s)	PLGA
Description	Characteristic properties of ester terminated poly(D,L-lactide-co-glycolide) (PLGA) are in vivo biodegradability, tunable drug release profile and very high encapsulation capacity.
Molecular Weight	50,000-75,000
Molecular Formula	[C3H4O2]x[C2H2O2]y
Feed Ratio	Lactide:Glycolide 85:15
Form	Amorphous
MDL Number	MFCD00131930
NACRES	NA.23
Quality Level	100
Storage Temp.	2-8°C
Packaging Information	1, 5 g in glass bottle
Shelf Life	ethyl acetate, chloroform, acetone and THF: soluble
Features and Benefits	Controlled release of bioactive agents, sutures and bioabsorbable implantable devices.
Application	PLGA polymers find uses in the production of biodegradable medical sutures and for controlled drug release. PLGA microspheres have been reported for use in controlled release of human growth hormone.
SMILES String	OCC(O)=O.CC(O)C(O)=O
Storage Class Code	11 - Combustible Solids
WGK	WGK 3
Flash Point(F)	Not applicable
Flash Point(C)	Not applicable

Please note: Our products and services are not intended to be used directly in diagnostic or therapeutic procedures.